Salivary Gland Cancer Organoids Are Valid for Preclinical Genotype-Oriented Medical Precision Trials

Researchers enrolled 29 patients, including 24 with salivary gland cancers and 5 with benign tumors. Resected tumors were subjected to organoid and monolayer cultures, as well as whole-exome sequencing.